DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HEMOGLOBIN RAFFIMER
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases
Unknown
HEMOGLOBIN RAFFIMER
×
Maximum Phase:
2
First Approval:
None
UNII:
69HRT16MGP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOFILTIC ACID I 123
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Unknown
IODOFILTIC ACID I 123
×
Maximum Phase:
2
First Approval:
None
UNII:
0J7USQ749M
Molecule Type:
Small molecule
Molecular Formula:
C22H35IO2
Molecular Weight:
454.43
AlogP:
7.24
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
NAPTUMOMAB ESTAFENATOX
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell
Trophoblast glycoprotein other
NAPTUMOMAB ESTAFENATOX
×
Maximum Phase:
2
First Approval:
None
UNII:
93T929W6LC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PARATHYROID HORMONE RELATED PROTEIN (1-36)
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PARATHYROID HORMONE RELATED PROTEIN (1-36)
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFIMETORAN
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
Unknown
AFIMETORAN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H32N6O
Molecular Weight:
444.58
AlogP:
4.28
PSA:
92.31
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FASORACETAM
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
FASORACETAM
×
Maximum Phase:
2
First Approval:
None
UNII:
42O8UF5CJB
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O2
Molecular Weight:
196.25
AlogP:
0.28
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
1.0
Source:
M-1095
2
Unknown
Investigational
Unknown
Unknown
Psoriasis
Interleukin 17A inhibitor
M-1095
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORVEPITANT MALEATE
2
Small molecule
Investigational
Unknown
Unknown
Cough
Unknown
ORVEPITANT MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HAX0H28B6W
Molecule Type:
Small molecule
Molecular Formula:
C35H39F7N4O6
Molecular Weight:
744.71
AlogP:
6.8
PSA:
47.1
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ENVAFOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Biliary Tract Neoplasms; Breast Neoplasms; Hepatitis B, Chronic; Neoplasms
Programmed cell death 1 ligand 1 binding agent
ENVAFOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
ES1M06M6QH
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STRONTIUM MALONATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
STRONTIUM MALONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HM781-36B
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HM781-36B
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AURICLOSENE MONOSODIUM MONOHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Conjunctivitis, Viral
Unknown
AURICLOSENE MONOSODIUM MONOHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4787JWS9HN
Molecule Type:
Small molecule
Molecular Formula:
C4H10Cl2NNaO4S
Molecular Weight:
262.09
AlogP:
1.26
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BFH-772
2
Small molecule
Investigational
Unknown
Unknown
Rosacea
Unknown
BFH-772
×
Maximum Phase:
2
First Approval:
None
UNII:
T1IV236CVP
Molecule Type:
Small molecule
Molecular Formula:
C23H16F3N3O3
Molecular Weight:
439.39
AlogP:
5.19
PSA:
84.34
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PRESATOVIR
2
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
PRESATOVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
9628AJ27JA
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN7O3S
Molecular Weight:
532.07
AlogP:
2.97
PSA:
125.93
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OLEOYL
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
OLEOYL
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H40NaO7P
Molecular Weight:
458.51
AlogP:
5.04
PSA:
113.29
HBD:
3.0
HBA:
#RotB:
20.0
Source:
PERFLENAPENT
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
PERFLENAPENT
×
Maximum Phase:
2
First Approval:
None
UNII:
483AU1Y5CZ
Molecule Type:
Small molecule
Molecular Formula:
C5F12
Molecular Weight:
288.03
AlogP:
4.02
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
2.0
Source:
RV-521
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RV-521
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMACTUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Neoplasms
Macrophage colony stimulating factor receptor inhibitor
EMACTUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
6FY6EI1X8R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FAPI GA-68
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FAPI GA-68
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C40H53GaN10O10
Molecular Weight:
903.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GLPG0634
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLPG0634
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAPITINIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
SAPITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
3499328002
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClFN5O3
Molecular Weight:
473.94
AlogP:
3.76
PSA:
88.61
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OBATOCLAX
2
Small molecule
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma; Leukemia, Myeloid, Acute
Unknown
OBATOCLAX
×
Maximum Phase:
2
First Approval:
None
UNII:
QN4128B52A
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O
Molecular Weight:
317.39
AlogP:
4.49
PSA:
53.17
HBD:
2.0
HBA:
#RotB:
3.0
Source:
INDOXIMOD
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Ependymoma; Gliosarcoma; Leukemia, Myeloid, Acute; Medulloblastoma; Breast Neoplasms; Melanoma; Prostatic Neoplasms
Unknown
INDOXIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
TX5CYN1KMZ
Molecule Type:
Small molecule
Molecular Formula:
C12H14N2O2
Molecular Weight:
218.26
AlogP:
1.13
PSA:
68.25
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VEBICORVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic
Unknown
VEBICORVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H12F3N3O4S2
Molecular Weight:
467.45
AlogP:
3.49
PSA:
105.23
HBD:
2.0
HBA:
#RotB:
3.0
Source:
IRX-4204
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Parkinson Disease; Carcinoma, Non-Small-Cell Lung; Prostatic Neoplasms, Castration-Resistant
Retinoid X receptor agonist
IRX-4204
×
Maximum Phase:
2
First Approval:
None
UNII:
877M97Z38Y
Molecule Type:
Small molecule
Molecular Formula:
C24H32O2
Molecular Weight:
352.52
AlogP:
5.9
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ETO
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ETO
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VESATOLIMOD
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; HIV Infections; Acquired Immunodeficiency Syndrome; Hepatitis B, Chronic
Toll-like receptor 7 activator
VESATOLIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
O8M467C50G
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6O2
Molecular Weight:
410.52
AlogP:
2.79
PSA:
96.61
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DAPANSUTRILE
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Melanoma; Schnitzler Syndrome; Severe Acute Respiratory Syndrome
NACHT, LRR and PYD domains-containing protein 3 inhibitor
DAPANSUTRILE
×
Maximum Phase:
2
First Approval:
None
UNII:
2Z03364G96
Molecule Type:
Small molecule
Molecular Formula:
C4H7NO2S
Molecular Weight:
133.17
AlogP:
-0.06
PSA:
57.93
HBD:
0.0
HBA:
#RotB:
2.0
Source:
SERIBANTUMAB
2
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Pancreatic Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
SERIBANTUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
1N3L70MDFX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADL-5747
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Osteoarthritis, Knee
Delta opioid receptor agonist
ADL-5747
×
Maximum Phase:
2
First Approval:
None
UNII:
BRJ718SA03
Molecule Type:
Small molecule
Molecular Formula:
C24H29ClN2O3
Molecular Weight:
428.96
AlogP:
3.82
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
IRX-2
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Breast Neoplasms; Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Squamous Intraepithelial Lesions
Unknown
IRX-2
×
Maximum Phase:
2
First Approval:
None
UNII:
ZDR4QSJ43F
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
P144
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
P144
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIROPEPIMUT-S
2
Unknown
Investigational
Unknown
Unknown
Squamous Cell Carcinoma of Head and Neck
Melanoma-associated antigen 3 vaccine antigen
BIROPEPIMUT-S
×
Maximum Phase:
2
First Approval:
None
UNII:
6XJF4EZC5Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TC-6987
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Diabetes Mellitus, Type 2
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
TC-6987
×
Maximum Phase:
2
First Approval:
None
UNII:
Q2U4R164OG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CB-103
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
CB-103
×
Maximum Phase:
2
First Approval:
None
UNII:
Q5BB91JL0V
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
3.75
PSA:
48.14
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
150
151
152
153
154
155
156
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA